Literature DB >> 6303851

Dissociation of human neutrophil membrane depolarization, respiratory burst stimulation and phospholipid metabolism by quinacrine.

A I Tauber, E R Simons.   

Abstract

Human neutrophils generate a respiratory burst with the elaboration of toxic oxygen metabolites upon appropriate stimulation. Subsequent to receptor-ligand interaction, the activation pathway of this burst is unknown. Here, attempts to correlate phospholipid turnover have demonstrated dissociation of lipid flux and burst activation. Quinacrine inhibited membrane depolarization, superoxide (O-2) generation, and net phosphatidylserine production with ID50-values of 16 microM and greater than 500 microM, respectively. The inhibitory profiles of these neutrophil activation parameters demonstrate a dissociation between membrane depolarization, respiratory burst stimulation, and phospholipid turnover.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6303851     DOI: 10.1016/0014-5793(83)80269-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  The superoxide-generating NADPH oxidase of human neutrophils is electrogenic and associated with an H+ channel.

Authors:  L M Henderson; J B Chappell; O T Jones
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

2.  The digestion of bacterial macromolecules by phagocytic cells: the effect of mepacrine and ethanol.

Authors:  P J Roberts; A W Segal
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

3.  Pharmacological characterization of the slow component of deactivation of guinea-pig isolated ileum to the spasmogenic action of C5adesArg.

Authors:  B Damerau; J Roesler; W Vogt
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

4.  Activation of the human neutrophil nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase by protein kinase C.

Authors:  J A Cox; A Y Jeng; N A Sharkey; P M Blumberg; A I Tauber
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.